Siddharth J. Modi

Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective

Siddharth J. Modi, Vithal M. Kulkarni · Medicine in Drug Discovery · 2019 · 300 citations · Full text

Angiogenesis Inhibition, Pathology, Pharmacotherapy +20

Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS)

Siddharth J. Modi, Anshuly Tiwari, Chetana Ghule et al. · Molecules · 2022 · 54 citations · Full text

Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma

Siddharth J. Modi, Vithal M. Kulkarni · European Journal of Medicinal Chemistry · 2020 · 34 citations

Epithelial-mesenchymal Transition, Tumor Biology, Medicine +11

Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis

V. G. Vaidya, Ninad Naik, Gayatri Ganu et al. · Journal of Ethnopharmacology · 2023 · 28 citations

Dunal Root Extract, Healthy Human Volunteers, Herbal Medicine +8

Clinical safety and tolerability evaluation of Withania somnifera (L.) Dunal (Ashwagandha) root extract in healthy human volunteers

V. G. Vaidya, Amol Gothwad, Gayatri Ganu et al. · Journal of Ayurveda and Integrative Medicine · 2023 · 25 citations · Full text